| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | -10.2% | +179.6% |
| Cost of Revenue | $351K | +7.7% | +54.6% |
| R&D Expense | $17.3M | -5.5% | -9.6% |
| SG&A Expense | $11.6M | +21.6% | -26.0% |
| Operating Income | -$27.5M | -4.9% | +20.3% |
| Pre-tax Income | -$29.8M | -16.1% | +18.6% |
| Income Tax | -$30K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $69.6M | +77.5% | -28.5% |
| Accounts Receivable | $891K | -22.2% | — |
| Inventory | $4.1M | +28.7% | +66.9% |
| Current Assets | $132.8M | +82.1% | -7.1% |
| Total Assets | $163.6M | +55.5% | -8.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$70.1M | — | — |
| Investing Cash Flow | -$8.7M | — | — |
| Financing Cash Flow | $92.5M | — | — |
| -181.1% |
| -300.0% |
| Net Income | -$29.8M | -15.8% | +18.8% |
| EPS (Basic) | -$0.69 | +80.1% | -283.3% |
| EPS (Diluted) | -$0.69 | +80.1% | -283.3% |
| $23.5M |
| +2.7% |
| -19.7% |
| Long-term Debt | $75.0M | +0.0% | +0.0% |
| Total Liabilities | $101.9M | +0.7% | -14.0% |
| Stockholders' Equity | $61.6M | +1451.7% | +3.4% |